Epstein Files Full PDF

CLICK HERE
Technopedia Center
PMB University Brochure
Faculty of Engineering and Computer Science
S1 Informatics S1 Information Systems S1 Information Technology S1 Computer Engineering S1 Electrical Engineering S1 Civil Engineering

faculty of Economics and Business
S1 Management S1 Accountancy

Faculty of Letters and Educational Sciences
S1 English literature S1 English language education S1 Mathematics education S1 Sports Education
teknopedia

  • Registerasi
  • Brosur UTI
  • Kip Scholarship Information
  • Performance
Flag Counter
  1. World Encyclopedia
  2. Essential fructosuria - Wikipedia
Essential fructosuria - Wikipedia
From Wikipedia, the free encyclopedia
Medical condition
Essential fructosuria
Other namesKetohexokinase deficiency[1]
Fructose
SpecialtyMedical genetics

Essential fructosuria, caused by a deficiency of the enzyme hepatic fructokinase, is a clinically benign condition characterized by the incomplete metabolism of fructose in the liver, leading to its excretion in urine.[2] Fructokinase (sometimes called ketohexokinase) is the first enzyme involved in the degradation of fructose to fructose-1-phosphate in the liver.[3]

This defective degradation does not cause any clinical symptoms, fructose is either excreted unchanged in the urine or metabolized to fructose-6-phosphate by alternate pathways in the body, most commonly by hexokinase in adipose tissue and muscle.[2]

Signs and symptoms

[edit]
[icon]
This section is empty. You can help by adding to it. (October 2024)

Cause

[edit]

Essential fructosuria is a genetic condition that is inherited in an autosomal recessive manner.[3] Mutations in the KHK gene, located on chromosome 2p23.3-23.2 are responsible. The incidence of essential fructosuria has been estimated at 1:130,000.[4] The actual incidence is likely higher, because those affected are asymptomatic.[citation needed]

Diagnosis

[edit]

A diagnosis of essential fructosuria is typically made after a positive routine test for reducing sugars in the urine. An additional test with glucose oxidase must also be carried out (with a negative result indicating essential fructosuria) as a positive test for reducing sugars is most often a result of glucosuria secondary to diabetes mellitus. The excretion of fructose in the urine is not constant, it depends largely on dietary intake.[5][2]

Treatment

[edit]

No treatment is indicated for essential fructosuria, while the degree of fructosuria depends on the dietary fructose intake, it does not have any clinical manifestations.[2] The amount of fructose routinely lost in urine is quite small.[6] Other errors in fructose metabolism have greater clinical significance. Hereditary fructose intolerance, or the presence of fructose in the blood (fructosemia), is caused by a deficiency of aldolase B, the second enzyme involved in the metabolism of fructose. [citation needed]

This enzyme deficiency results in an accumulation of fructose-1-phosphate, which inhibits the production of glucose and results in diminished regeneration of adenosine triphosphate. Clinically, patients with hereditary fructose intolerance are much more severely affected than those with essential fructosuria, with elevated uric acid, growth abnormalities and can result in coma if untreated.[2]

References

[edit]
  1. ^ "Essential fructosuria". Orphanet. Retrieved 11 April 2019.
  2. ^ a b c d e Steinmann B, Santer R (2012). "Disorders of Fructose Metabolism". In Saudubray JM, van den Berghe G, Walter JH (eds.). Inborn Metabolic Diseases: Diagnosis and Treatment (5th ed.). New York: Springer. pp. 157–165. ISBN 978-3-642-15719-6.
  3. ^ a b Online Mendelian Inheritance in Man (OMIM): 229800
  4. ^ Steinmann B, Santer R, van den Berghe G (2006). "9.1 Essential Fructosuria]" (PDF). In Berghe G, Fernandes J, Saudubray JM, Walter JH (eds.). Inborn Metabolic Diseases. Diagnosis and Treatment (fourth ed.). Springer. p. 137. ISBN 978-3-540-28783-4.
  5. ^ Tran C (April 2017). "Inborn Errors of Fructose Metabolism. What Can We Learn from Them?". Nutrients. 9 (4): 356. doi:10.3390/nu9040356. PMC 5409695. PMID 28368361.
  6. ^ Katz J, Benumof J, Kadis LB (1990). Anesthesia and Uncommon Diseases (third ed.). Philadelphia: Saunders. ISBN 978-0-7216-2367-2.

External links

[edit]
Classification
D
  • ICD-10: E74.1
  • ICD-9-CM: 271.2
  • OMIM: 229800
  • MeSH: C538068
  • DiseasesDB: 5001
  • v
  • t
  • e
Inborn error of carbohydrate metabolism: monosaccharide metabolism disorders
Including glycogen storage diseases (GSD)
Sucrose, transport
(extracellular)
Disaccharide catabolism
  • Congenital alactasia
  • Sucrose intolerance
Monosaccharide transport
  • Glucose-galactose malabsorption
  • Inborn errors of renal tubular transport (Renal glycosuria)
  • Fructose malabsorption
  • De Vivo Disease (GLUT1 deficiency)
  • Fanconi-Bickel syndrome (GLUT2 deficiency)
Hexose → glucose
Monosaccharide catabolism
Fructose:
  • Essential fructosuria
  • Fructose intolerance
Galactose / galactosemia:
  • GALK deficiency
  • GALT deficiency/GALE deficiency
Glucose ⇄ glycogen
Glycogenesis
  • GSD type 0 (glycogen synthase deficiency)
  • GSD type IV (Andersen's disease, branching enzyme deficiency)
  • Adult polyglucosan body disease (APBD)
  • Lafora disease
  • GSD type XV (glycogenin deficiency)
Glycogenolysis
Extralysosomal:
  • GSD type III (Cori's disease, debranching enzyme deficiency)
  • GSD type VI (Hers' disease, liver glycogen phosphorylase deficiency)
  • GSD type V (McArdle's disease, myophosphorylase deficiency)
  • GSD type IX (phosphorylase kinase deficiency)
  • Phosphoglucomutase deficiency (PGM1-CDG, CDG1T, formerly GSD-XIV)
Lysosomal (LSD):
  • Glycogen storage disease type II (Pompe's disease, glucosidase deficiency, formerly GSD-IIa)
  • Danon disease (LAMP2 deficiency, formerly GSD-IIb)
Glucose ⇄ CAC
Glycolysis
  • MODY 2/HHF3
  • GSD type VII (Tarui's disease, phosphofructokinase deficiency)
  • Triosephosphate isomerase deficiency
  • Pyruvate kinase deficiency
  • Aldolase A deficiency
  • Phosphoglucose isomerase deficiency
  • Phosphoglycerate kinase deficiency
  • Mitochondrial pyruvate carrier deficiency (MPC1 deficiency)
Gluconeogenesis
  • Pyruvate carboxylase deficiency
  • Fructose bisphosphatase deficiency
  • GSD type I (von Gierke's disease, glucose 6-phosphatase deficiency)
Pentose phosphate pathway
  • Glucose-6-phosphate dehydrogenase deficiency
  • Transaldolase deficiency
  • SDDHD (Transketolase deficiency)
  • 6-phosphogluconate dehydrogenase deficiency
Other
  • Hyperoxaluria
    • Primary hyperoxaluria
  • Pentosuria
  • Fatal congenital nonlysosomal cardiac glycogenosis (AMP-activated protein kinase deficiency, PRKAG2)
Retrieved from "https://teknopedia.ac.id/w/index.php?title=Essential_fructosuria&oldid=1305979072"
Categories:
  • Autosomal recessive disorders
  • Inborn errors of carbohydrate metabolism
Hidden categories:
  • Articles with short description
  • Short description matches Wikidata
  • Articles to be expanded from October 2024
  • All articles to be expanded
  • Articles with empty sections from October 2024
  • All articles with empty sections
  • All articles with unsourced statements
  • Articles with unsourced statements from September 2021

  • indonesia
  • Polski
  • العربية
  • Deutsch
  • English
  • Español
  • Français
  • Italiano
  • مصرى
  • Nederlands
  • 日本語
  • Português
  • Sinugboanong Binisaya
  • Svenska
  • Українська
  • Tiếng Việt
  • Winaray
  • 中文
  • Русский
Sunting pranala
url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url
Pusat Layanan

UNIVERSITAS TEKNOKRAT INDONESIA | ASEAN's Best Private University
Jl. ZA. Pagar Alam No.9 -11, Labuhan Ratu, Kec. Kedaton, Kota Bandar Lampung, Lampung 35132
Phone: (0721) 702022
Email: pmb@teknokrat.ac.id